πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 50 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12391658

Sulfoxide and sulfone glucokinase activators and methods of use thereof

VTV THERAPEUTICS LLC Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12091407

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use t

VTV THERAPEUTICS LLC Β· Granted Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11974989

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC Β· Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11970457

Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-p

VTV THERAPEUTICS LLC Β· Granted Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11883383

Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-im

VTV THERAPEUTICS LLC Β· Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11833136

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC Β· Granted Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11649230

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use t

VTV THERAPEUTICS LLC Β· Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11524942

Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-p

VTV THERAPEUTICS LLC Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11420942

Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -ph

VTV THERAPEUTICS LLC Β· Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11420929

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

VTV THERAPEUTICS LLC Β· Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11130753

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use t

VTV THERAPEUTICS LLC Β· Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11096946

Use of a PPAR-Ξ΄ agonist for reducing loss of muscle strength, muscle mass, or type I muscl

VTV THERAPEUTICS LLC Β· Granted Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10980861

Glucokinase activator compositions for the treatment of diabetes

VTV THERAPEUTICS LLC Β· Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10952993

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10947180

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

VTV THERAPEUTICS LLC Β· Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10898475

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions there

VTV THERAPEUTICS LLC Β· Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10889580

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use t

VTV THERAPEUTICS LLC Β· Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10588943

Glucokinase activator compositions for the treatment of diabetes

VTV THERAPEUTICS LLC Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10568888

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10570126

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use t

VTV THERAPEUTICS LLC Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10471066

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

VTV THERAPEUTICS LLC Β· Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10463652

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions there

VTV THERAPEUTICS LLC Β· Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10456406

Use of a PPAR-Ξ΄ agonist for reducing loss of muscle strength, muscle mass, or type I muscl

VTV THERAPEUTICS LLC Β· Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10391097

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted